| 中文名称Chinese name
|
MERS-CoV EMC2012滴鼻感染hDPP4-Tg小鼠模型 |
| 编号Model number |
|
| 英文名称English name |
MERS-CoV EMC2012 intransally infection hDPP4-Tg mouse model |
| 物种Species name |
小鼠
|
| 品系Strain name |
|
| 人类疾病Human diseases |
MERS |
| 传染性Infectivity |
是 |
| 微生物Microorganism |
|
| 类别Category |
MERS-CoV感染动物模型 |
| 造模因素Modeling factors |
|
| 制作方法Making method |
Mice under lethal virus infection were intranasally inoculated with 104.6 TCID50 MERS-CoV (EMC2012 strain) in 20 µl Dulbecco’s modified Eagle’s medium (DMEM). After 24 h, the mice were intravenously injected with 2 mg/kg purified hMS-1 or the trastuzumab mAb control. |
| 生物学特征Biological characteristics |
|
| 医学用途Medical use |
用于MERS致病机制研究、疫苗和药物评估。 |
| 临床表现Clinical manifestation |
|
| 病理表现Pathology |
|
| 发病天数Days of onset |
|
| 发病过程Pathogenesis process |
|
| 临床诊断Clinical diagnosis |
|
| 评价模型成功的指标Indicators for evaluating model success |
|
| 保藏单位Preservation unit |
病原微生物生物安全国家重点实验室@@https://www.natureindex.com/institution-outputs/china/state-key-laboratory-of-pathogen-and-biosecurity-amms/55010c6f140ba079548b4567 |
| 参考文献Reference |
Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection.,PMID:27312105,DOI:10.1038/nmicrobiol.2016.289 |
| 录入/更新时间Date |
2021.7.20 |
| 备注Remarks |
|
当前位置：
